Hospira Granted Temporary Restraining Order Against FDA, Shares Pop Higher

Loading...
Loading...
Shares of Hospira Inc.
HS
are trading higher after the company was granted a temporary restraining order against the U.S. Food and Drug Administration over the agency's approval of generic versions of the company's top-selling drug, Precedex. Precedex is a sedative that accounts for nearly 11 percent of Hospira's total revenue. Shares of HSP are up 1.7 percent in today's trading.
Posted In: News
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...